The role of 18F-FDG-PET and PET/CT in patients with colorectal liver metastases undergoing selective internal radiation therapy with yttrium-90: a first evidence-based review.
Détails
ID Serval
serval:BIB_42907B7903E7
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
The role of 18F-FDG-PET and PET/CT in patients with colorectal liver metastases undergoing selective internal radiation therapy with yttrium-90: a first evidence-based review.
Périodique
TheScientificWorldJournal
ISSN
1537-744X (Electronic)
ISSN-L
1537-744X
Statut éditorial
Publié
Date de publication
2014
Peer-reviewed
Oui
Volume
2014
Pages
879469
Langue
anglais
Notes
Publication types: Journal Article ; Meta-Analysis ; Review
Publication Status: epublish
Publication Status: epublish
Résumé
To provide a first evidence-based review of the literature on the role of fluorine-18-fluorodeoxyglucose positron emission tomography and positron emission tomography/computed tomography (FDG-PET and PET/CT) in patients with colorectal liver metastases (CRLM) undergoing selective internal radiation therapy (SIRT) with yttrium-90 ((90)Y) microspheres.
A comprehensive computer literature search was conducted to find relevant published articles on whole-body FDG-PET or PET/CT in patients with CRLM undergoing SIRT.
We identified 19 studies including 833 patients with CRLM undergoing SIRT. The role of FDG-PET or PET/CT was analysed in treatment planning, treatment response evaluation, and as prognostic tool.
FDG-PET and PET/CT provide additional information in treatment evaluation of CRLM patients treated with SIRT and may have a role in treatment planning and patient selection. FDG-PET/CT is emerging as good prognostic tool in these patients.
A comprehensive computer literature search was conducted to find relevant published articles on whole-body FDG-PET or PET/CT in patients with CRLM undergoing SIRT.
We identified 19 studies including 833 patients with CRLM undergoing SIRT. The role of FDG-PET or PET/CT was analysed in treatment planning, treatment response evaluation, and as prognostic tool.
FDG-PET and PET/CT provide additional information in treatment evaluation of CRLM patients treated with SIRT and may have a role in treatment planning and patient selection. FDG-PET/CT is emerging as good prognostic tool in these patients.
Mots-clé
Colorectal Neoplasms/pathology, Fluorodeoxyglucose F18, Humans, Liver Neoplasms/diagnosis, Liver Neoplasms/mortality, Liver Neoplasms/radiotherapy, Liver Neoplasms/secondary, Positron-Emission Tomography, Prognosis, Tomography, X-Ray Computed, Treatment Outcome, Yttrium Radioisotopes
Pubmed
Web of science
Open Access
Oui
Création de la notice
20/08/2017 19:26
Dernière modification de la notice
20/08/2019 14:45
Données d'usage
